Tag archief: English Only

Murex Wins Software Solution of the Year in the FTF News Technology Innovation Awards 2018

PARIS–(BUSINESS WIRE)– FTF News announces that Murex is among the top systems in the prestigious 2018 Awards Murex, an industry leader in trading, risk management...

Arthur D. Little Predicts Innovative Next-Generation Lithium-ion Technology Will Triumph in the Future Battery Market

LONDON–(BUSINESS WIRE)– Arthur D. Little (ADL) today released a new study, “Future of batteries: Winner takes all?” Based on extensive market analysis, the report examines...

DXC Technology Appointed as a Preferred Systems Integrator for Workplace and Mobility Services by Zurich

TYSONS, Va.–(BUSINESS WIRE)– DXC Technology (NYSE:DXC) today announced that it has signed an agreement with Zurich Insurance Company Ltd (Zurich), a leading global, multi-line insurance...

ADM Announces Proposed Acquisition of Neovia, Establishing a Premier Global Leader in Value-Added Animal Nutrition Solutions

CHICAGO–(BUSINESS WIRE)– €1.535 billion addition marks another major milestone in the execution of ADM’s strategic plan and portfolio transformation Addition of Neovia, a France-headquartered global...

Alibaba Cloud Launches EMEA Partner Program

PARIS–(BUSINESS WIRE)– Bringing Global Brands Together to Drive Digital Transformation in EMEA Alibaba Cloud, the cloud computing arm of the Alibaba Group, today launched the...

New Analysis of Rekovelle® Data Further Supports Use of AMH to Personalise Fertility Treatment

New Analysis of Rekovelle® Data Further Supports Use of AMH to Personalise Fertility Treatment SAINT-PREX, Switzerland–(BUSINESS WIRE)– Rekovelle’s unique dosing algorithm, which is based on a...

Bankdata Expands Use of Murex’s Capital Markets Platform, MX.3

PARIS–(BUSINESS WIRE)– – Innovative Bank Utility Model Helps Secure the Future for 11 Danish Banks – Bankdata, an IT service provider to the Danish banking...

CHMP issues positive opinion to expand Jardiance®, Synjardy® and Glyxambi® labels to include positive effects on cardiovascular and renal outcomes

INGELHEIM, Germany & INDIANAPOLIS–(BUSINESS WIRE)– European labels for Jardiance®, Synjardy® and Glyxambi® expanded to include positive effects on cardiovascular and renal endpoints from landmark EMPA-REG...

World Scleroderma Day 2018: Families open up about supporting a loved one with scleroderma, in new video series

INGELHEIM, Germany–(BUSINESS WIRE)– Boehringer Ingelheim provides platform to families and loved ones of people living with scleroderma with new, insightful stories, sharing ways to cope...

Philip Morris International Makes Another Step towards a Smoke-Free Future Through Partnership with Physician-Founded Start-up

LAUSANNE, Switzerland–(BUSINESS WIRE)– Parallax Development Corp. (“Parallax”) and Philip Morris International (“PMI”) will join forces to develop innovations in alternative nicotine-delivery platforms. Parallax is a...

Ant Financial’s Ji Xu Named to MIT Technology Review’s 2018 Innovators Under 35 List

HANGZHOU, China–(BUSINESS WIRE)– Today, Ant Financial Services Group, parent company of Alipay, announced that its payments technology expert Ji Xu has been named to MIT...

New patient survey reveals: For people with atrial fibrillation, reversal of their blood thinning treatment is highly important

INGELHEIM, Germany–(BUSINESS WIRE)– 89% of surveyed patients with atrial fibrillation (AF) are aware of potential complications which may arise due to their blood thinning treatment...

IFF Launches New Environmental Goals with Ambitious Science-Based Targets

NEW YORK–(BUSINESS WIRE)– Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF), a leading innovator of sensory experiences that move the world, today launched...

American Express Wins Major Antitrust Lawsuit

NEW YORK–(BUSINESS WIRE)– Supreme Court Decision Reinforces American Express’ Differentiated Business Model and Supports Consumer Choice American Express (NYSE:AXP) issued the following statement today from...

Boehringer Ingelheim and Lilly announce positive top-line Phase III data results for empagliflozin as adjunct to insulin in type 1 diabetes

INGELHEIM, Germany and INDIANAPOLIS–(BUSINESS WIRE)– Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced that both randomised controlled trials in the EASE phase...